Binding mode of Pyridoclax to Myeloid cell leukemia-1 (Mcl-1) revealed by Nuclear Magnetic Resonance Spectroscopy, Docking and Molecular Dynamics Approaches

Abstract : Myeloid cell leukemia-1 (Mcl-1) is an anti-apoptotic member of the Bcl-2 family proteins. Its amplification is one of the most frequent genetic aberrations found in human cancers. Pyridoclax, a promising BH3 mimetic inhibitor, interacts directly with Mcl-1 and induces massive apoptosis at a concentration of 15 µM in combination with anti-Bcl-xL strategies in chemo-resistant ovarian cancer cell lines. In this study, a combined experimental and theoretical approach was used to investigate the binding mode of Pyridoclax to Mcl-1. The representative poses generated from dynamics simulations compared with NMR data revealed: (i) Pyridoclax bound to P1 and P2 pockets of Mcl-1 BH3 binding groove through its styryl and methyl groups establishing mainly hydrophobic contacts, (ii) one of the ending pyridines interacts through electrostatic interaction with K234 side chain, a negatively charged residue present only in this position in Mcl-1.
Type de document :
Article dans une revue
Domaine :
Liste complète des métadonnées

https://hal-normandie-univ.archives-ouvertes.fr/hal-02330946
Contributeur : Madeleine Roux-Merlin <>
Soumis le : jeudi 24 octobre 2019 - 11:10:25
Dernière modification le : vendredi 8 novembre 2019 - 16:28:04

Identifiants

Citation

A. Bourafai-Aziez, M. Sebban, M. Benabderrahmane, B. Marekha, C. Denis, et al.. Binding mode of Pyridoclax to Myeloid cell leukemia-1 (Mcl-1) revealed by Nuclear Magnetic Resonance Spectroscopy, Docking and Molecular Dynamics Approaches. Journal of Biomolecular Structure and Dynamics, Taylor & Francis: STM, Behavioural Science and Public Health Titles, 2019, pp.1-26. ⟨10.1080/07391102.2019.1680434⟩. ⟨hal-02330946⟩

Partager

Métriques

Consultations de la notice

11